Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.86 USD | +2.27% |
|
-0.39% | -6.05% |
Feb. 05 | Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay | MT |
Feb. 05 | Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay | RE |
Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|---|---|
+2.27% | -0.39% | -9.80% | -20.35% | -6.05% | -44.12% | -50.91% | -35.41% | -61.70% | 1.14B | ||
-0.52% | -2.65% | +3.36% | +10.39% | +9.86% | +10.82% | +12.52% | +22.92% | +256.09% | 13.96B | ||
+0.81% | +2.57% | +2.32% | -5.58% | -10.39% | -13.43% | +67.08% | - | - | 6.77B | ||
+0.74% | -8.90% | -12.95% | -3.24% | -7.90% | +45.69% | +189.70% | +387.51% | - | 5.7B | ||
+0.08% | -3.10% | -1.76% | -8.48% | +0.10% | +13.53% | -16.78% | -13.19% | +181.53% | 5.49B | ||
+3.08% | -5.41% | +18.16% | +51.43% | +47.36% | +93.80% | -35.69% | -45.63% | - | 5.39B | ||
-1.05% | +1.52% | +1.72% | -12.27% | -6.74% | -25.18% | -18.11% | -55.55% | - | 3.22B | ||
-1.22% | +8.37% | +9.20% | -9.13% | +5.39% | +7.42% | -27.24% | +586.58% | +53.12% | 2.75B | ||
-1.05% | -8.02% | -1.05% | -16.46% | -7.67% | +7.94% | -46.09% | +9.43% | +467.14% | 2.5B | ||
+2.34% | +8.33% | +7.95% | -8.07% | -3.70% | +7.74% | -33.42% | - | - | 1.67B | ||
+2.20% | +24.83% | +42.93% | -3.73% | +28.12% | +35.61% | +84.71% | +82.89% | - | 1.65B | ||
-0.62% | +1.21% | +5.72% | -14.87% | +0.62% | -14.49% | -35.13% | -53.27% | - | 1.48B | ||
+2.12% | -17.55% | -22.85% | -22.70% | -15.60% | -75.32% | -86.45% | -86.01% | - | 1.43B | ||
-1.96% | +6.58% | +9.06% | -10.76% | +9.12% | +33.54% | -9.92% | +18.71% | -53.12% | 1.34B | ||
-1.82% | +8.84% | +6.74% | -15.61% | -0.61% | +15.14% | -22.29% | -14.87% | - | 1.24B | ||
-1.92% | +8.41% | +14.85% | -3.64% | +7.11% | -26.99% | -12.10% | -11.28% | -22.44% | 1.17B | ||
-0.39% | +3.56% | +4.32% | -13.41% | -3.11% | +1.91% | -51.44% | -58.34% | - | 1.07B | ||
-2.27% | -10.62% | -14.39% | +21.91% | +0.68% | -14.11% | -82.75% | - | - | 892M | ||
-0.40% | +4.42% | +5.69% | -14.88% | -0.13% | -18.65% | -14.29% | -40.97% | - | 875M | ||
-19.75% | -.--% | -.--% | -.--% | -.--% | -20.56% | -41.21% | - | - | 814M | ||
Average | -0.96% | -1.93% | +3.46% | -4.97% | +2.32% | +1.02% | -11.49% | +43.35% | +117.23% | 3.03B | |
Weighted average by Cap. | -0.06% | -1.73% | +3.11% | +1.16% | +4.63% | +12.22% | +13.15% | +68.54% | +201.69% |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.